TY - JOUR
T1 - Characterization of Melan-A reactive memory CD8+ T cells in a healthy donor
AU - Voelter, Verena
AU - Rufer, Nathalie
AU - Reynard, Severine
AU - Greub, Gilbert
AU - Brookes, Roger
AU - Guillaume, Philippe
AU - Grosjean, Frederic
AU - Fagerberg, Theres
AU - Michelin, Olivier
AU - Rowland-Jones, Sarah
AU - Pinilla, Clemencia
AU - Leyvraz, Serge
AU - Romero, Pedro
AU - Appay, Victor
PY - 2008/8
Y1 - 2008/8
N2 - Melan-A specific CD8+ T cells are thought to play an important role against the development of melanoma. Their in vivo expansion is often observed with advanced disease. In recent years, low levels of Melan-A reactive CD8+ T cells have also been found in HLA-A2 healthy donors, but these cells harbor naive characteristics and are thought to be mostly cross-reactive for the Melan-A antigen. Here, we report on a large population of CD8+ T cells reactive for the Melan-A antigen, identified in one donor with no evidence of melanoma. Interestingly, this population is oligoclonal and displays a clear memory phenotype. However, a detailed study of these cells indicated that they are unlikely to be directly specific for melanoma, so that their in vivo expansion may have been driven by an exogenous antigen. Screening of a Melan-A cross-reactive peptide library suggested that these cells may be specific for an epitope derived from a Mycobacterium protein, which would provide a further example of CD8+ T cell cross-reactivity between a pathogen antigen and a tumor antigen. Finally, we discuss potential perspectives regarding the role of such cells in heterologous immunity, by influencing the balance between protective immunity and pathology, e.g. in the case of melanoma development.
AB - Melan-A specific CD8+ T cells are thought to play an important role against the development of melanoma. Their in vivo expansion is often observed with advanced disease. In recent years, low levels of Melan-A reactive CD8+ T cells have also been found in HLA-A2 healthy donors, but these cells harbor naive characteristics and are thought to be mostly cross-reactive for the Melan-A antigen. Here, we report on a large population of CD8+ T cells reactive for the Melan-A antigen, identified in one donor with no evidence of melanoma. Interestingly, this population is oligoclonal and displays a clear memory phenotype. However, a detailed study of these cells indicated that they are unlikely to be directly specific for melanoma, so that their in vivo expansion may have been driven by an exogenous antigen. Screening of a Melan-A cross-reactive peptide library suggested that these cells may be specific for an epitope derived from a Mycobacterium protein, which would provide a further example of CD8+ T cell cross-reactivity between a pathogen antigen and a tumor antigen. Finally, we discuss potential perspectives regarding the role of such cells in heterologous immunity, by influencing the balance between protective immunity and pathology, e.g. in the case of melanoma development.
KW - Cross-reactivity
KW - Melanoma
KW - Mycobacterium
KW - T lymphocytes
KW - Tumor immunity
UR - https://www.scopus.com/pages/publications/48249104611
UR - https://www.scopus.com/pages/publications/48249104611#tab=citedBy
U2 - 10.1093/intimm/dxn066
DO - 10.1093/intimm/dxn066
M3 - Article
C2 - 18573812
AN - SCOPUS:48249104611
SN - 0953-8178
VL - 20
SP - 1087
EP - 1096
JO - International Immunology
JF - International Immunology
IS - 8
ER -